# VZV Vaccine for Hematopoietic Stem Cell Transplantation

> **NCT02329457** · PHASE2,PHASE3 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 100 (actual)

## Conditions studied

- Varicella Zoster Infection

## Interventions

- **BIOLOGICAL:** Zostavax
- **BIOLOGICAL:** Normal Saline

## Key facts

- **NCT ID:** NCT02329457
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2019-09
- **Final completion:** 2019-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02329457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02329457, "VZV Vaccine for Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02329457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*